Paper39201739
Serum TLR2 and TLR9 in Prostate Cancer Patients in Relation to EBV Status.
Sikora D and 4 others. Int J Mol Sci, 2024. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Serum TLR2 and TLR9 in Prostate Cancer Patients in Relation to EBV Status. Papers, record 39201739. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201739
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Toll-Like Receptor 2 | Major topic |
| Toll-Like Receptor 9 | Major topic |
| Epstein-Barr Virus Infections | Major topic |
| Herpesvirus 4, Human | Major topic |
| Humans | |
| Male | |
| Aged | |
| Middle Aged | |
| Neoplasm Grading |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| DS 233 | Medical University of Lublin | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20980631 | EBV latent membrane protein 1 is a negative regulator of TLR9. | J Immunol | 2010 | https://conductscience.org/library/papers/20980631 | PubMed |
| 2 | 33228078 | Epstein-Barr Virus: How Its Lytic Phase Contributes to Oncogenesis. | Microorganisms | 2020 | https://conductscience.org/library/papers/33228078 | PubMed |
| 3 | 35729214 | Detection and characterization of latency stage of EBV and histopathological analysis of prostatic adenocarcinoma tissues. | Sci Rep | 2022 | https://conductscience.org/library/papers/35729214 | PubMed |
| 4 | 37760627 | Epstein-Barr Virus Infection in Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37760627 | PubMed |
| 5 | 22851253 | Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer. | Prostate | 2013 | https://conductscience.org/library/papers/22851253 | PubMed |
| 6 | 29496646 | Viral etiology of prostate cancer: Genetic alterations and immune response. A literature review. | Int J Surg | 2018 | https://conductscience.org/library/papers/29496646 | PubMed |
| 7 | 27052804 | Differential expression of EBV proteins LMP1 and BHFR1 in EBV‑associated gastric and nasopharyngeal cancer tissues. | Mol Med Rep | 2016 | https://conductscience.org/library/papers/27052804 | PubMed |
| 8 | 34749760 | Anti-viral and pro-inflammatory functions of Toll-like receptors during gamma-herpesvirus infections. | Virol J | 2021 | https://conductscience.org/library/papers/34749760 | PubMed |
| 9 | 25101092 | Toll-like receptors and prostate cancer. | Front Immunol | 2014 | https://conductscience.org/library/papers/25101092 | PubMed |
| 10 | 38254816 | Can the Epstein-Barr Virus Play a Role in the Development of Prostate Cancer? | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38254816 | PubMed |
| 11 | 22291478 | Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates. | Clin Epidemiol | 2012 | https://conductscience.org/library/papers/22291478 | PubMed |
| 12 | 37637768 | Epstein-Barr Viral Infection and the Risk for Breast Cancer: A Systematic Review. | Int J Hematol Oncol Stem Cell Res | 2023 | https://conductscience.org/library/papers/37637768 | PubMed |
| 13 | 32584450 | Prostate cancer cells modulate the differentiation of THP-1 cells in response to etoposide and TLR agonists treatments. | Cell Biol Int | 2020 | https://conductscience.org/library/papers/32584450 | PubMed |
| 14 | 26046794 | TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells. | Oncotarget | 2015 | https://conductscience.org/library/papers/26046794 | PubMed |
| 15 | 33488588 | Epstein-Barr Virus and Systemic Autoimmune Diseases. | Front Immunol | 2020 | https://conductscience.org/library/papers/33488588 | PubMed |
| 16 | 31341086 | Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31341086 | PubMed |
| 17 | 37065193 | The innate and T-cell mediated immune response during acute and chronic gammaherpesvirus infection. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37065193 | PubMed |
| 18 | 31068988 | Epidemiology of Prostate Cancer. | World J Oncol | 2019 | https://conductscience.org/library/papers/31068988 | PubMed |
| 19 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 20 | 22311043 | Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population. | Mol Biol Rep | 2012 | https://conductscience.org/library/papers/22311043 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41601666 | Current update on toll-like receptors and prostate cancer: a decade of progress and emerging insights. | Front Immunol | 2025 | https://conductscience.org/library/papers/41601666 | PubMed |
| 40727252 | Toll-Like Receptors in the Immunotherapy Era: Dual-Edged Swords of Tumor Immunity and Clinical Translation. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40727252 | PubMed |
| 40151299 | Significant up-regulation of Toll-like receptor (TLR) signaling pathway in Epstein-Barr virus-associated gastric cancer. | Int J Mol Epidemiol Genet | 2025 | https://conductscience.org/library/papers/40151299 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TLR2 | 7097 | PubTator's text mining | https://conductscience.org/library/genes/7097 | NCBI Gene |
| TLR9 | 54106 | PubTator's text mining | https://conductscience.org/library/genes/54106 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201739
GET https://conductscience.org/api/papers/v1/39201739/references?page=2